Picture of COSCIENS Biopharma logo

CSCI — COSCIENS Biopharma News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Aeterna Zentaris Q4 Loss Per Share $0.31

March 26 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS REPORTS FOURTH QUARTER AND FULL-YEAR 2018
FINANCIAL AND OPERATING RESULTS
    * Q4 LOSS PER SHARE $0.31
    * TOTAL REVENUE FOR Q4 2018 WAS $1.4 MILLION, COMPARED TO
$0.2
MILLION FOR Q4 2017
    * AS OF DECEMBER 31, 2018, CO HAD $14.5 MILLION OF
UNRESTRICTED
CASH AND CASH EQUIVALENTS

Source text for Eikon:  ID:nGNX5Jrn8y 
Further company coverage:  AEZS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on COSCIENS Biopharma

See all news